Mankind Pharma Limited — Others, 26-03-2025: Trading Window

Mankind Pharma Limited has announced the closure of the trading window for its securities, effective from April 01, 2025, until 48 hours after the financial results for the quarter and half-year are declared. This measure impacts designated persons and their immediate relatives, aligning with insider trading regulations. The date of the board meeting for the financial results will be communicated later. This closure may cause cautious sentiment among investors as it indicates upcoming significant disclosures, presenting both an opportunity for informed trading once results are announced and a potential risk due to uncertainty in the interim.